L'Oreal's Q1 sales better than expected
*
Driven by Europe, North America
*
Sales at consumer division, company's biggest, grew 11.1%
(Recasts with analyst comment, detail throughout)
By Dominique Patton and Mimosa Spencer
PARIS, April 18 (Reuters) - L'Oreal reported a 9.4% rise in first quarter sales on a like-for-like basis on Thursday, beating expectations and easing concerns about a slowdown in the two biggest beauty markets the United States and China.
The French cosmetics giant, which owns the Maybelline and Lancome brands, reported sales of 11.24 billion euros ($11.98 billion) for 메이저사이트 the first three months to the end of Ma
r />The sales growth exceeded a consensus of a 6.1% rise cited by analysts at Jefferies. Sales were up 8.3% on a reported ba
r />L'Oreal, the world's biggest beauty company, said sales in both North America and Europe grew by more than 12%, as its mass market range and dermatological products compensated for weakness in the luxury segm
r />The West "continues to power on," Jefferies analysts said following the results, adding North America had defied weakening scanner data and downbeat retailer comment
r />U.S. retailer Ulta Beauty earlier this month rattled the market with comment about a faster-than-expected slowdown in the United States that hit shares across the sec
r />Following Thursday's results, L'Oreal's American depositary receipts (ADRs) gained as much as 6.5% in New York trading, while shares in U.S. rivals Estee Lauder and Coty also r
r />CONSUMER PRODUCTS
r />L'Oreal said its consumer products division, which includes its L'Oreal Paris range of mascaras and Elseve hair gloss and accounts for more than a third of its revenues, grew 11.1% on a like-for-like ba
r />The company benefited from higher volumes as well as value in the unit, with strong demand in Europe and emerging mark
r />The smaller but fast-growing dermatological beauty unit, which sells La Roche-Posay and CeraVe skincare, grew 21.9%, as it continued to benefit from medical recommendati
r />Sales in the luxury division that markets fragrances such as YSL's Libre and Aesop products acquired last year, grew by 1.8%, beating expectations for a decline, as strong growth in Europe and North America helped offset softness in North A
r />North Asia suffered from an unfavourable comparison base in Travel Retail and sluggish market growth in mainland China, the company s
r />Jefferies analysts said travel retail sales were also dented by a Chinese government crackdown on resellers of foreign consumer products, known as "daig
r />L'Oreal has the biggest share of China's luxury beauty market, or about 34%, Chief Executive Nicolas Hieronimus told analysts on a c
r />"We are unhappy about the fact that this market is not rebounding the way we expected it to rebound," he said, but added that the company is still outperforming the mar
r />The company grew 6.2% in China, compared to less than 1% in the broader market, he said.
r />Shares in L'Oreal, Europe's 6th most valuable listed company, with a market capitalisation of about 220 billion euro ($234.26 billion), have lost 6% so far this year, compared to a 5% fall at U.S. peer Estee Lauder. ($1 = 0.9383 eu
r />(Reporting by Dominique Patton and Mimosa Spencer; Editing by Susan Fenton and Barbara Lewis)
*
Driven by Europe, North America
*
Sales at consumer division, company's biggest, grew 11.1%
(Recasts with analyst comment, detail throughout)
By Dominique Patton and Mimosa Spencer
PARIS, April 18 (Reuters) - L'Oreal reported a 9.4% rise in first quarter sales on a like-for-like basis on Thursday, beating expectations and easing concerns about a slowdown in the two biggest beauty markets the United States and China.
The French cosmetics giant, which owns the Maybelline and Lancome brands, reported sales of 11.24 billion euros ($11.98 billion) for 메이저사이트 the first three months to the end of Ma
r />The sales growth exceeded a consensus of a 6.1% rise cited by analysts at Jefferies. Sales were up 8.3% on a reported ba
r />L'Oreal, the world's biggest beauty company, said sales in both North America and Europe grew by more than 12%, as its mass market range and dermatological products compensated for weakness in the luxury segm
r />The West "continues to power on," Jefferies analysts said following the results, adding North America had defied weakening scanner data and downbeat retailer comment
r />U.S. retailer Ulta Beauty earlier this month rattled the market with comment about a faster-than-expected slowdown in the United States that hit shares across the sec
r />Following Thursday's results, L'Oreal's American depositary receipts (ADRs) gained as much as 6.5% in New York trading, while shares in U.S. rivals Estee Lauder and Coty also r
r />CONSUMER PRODUCTS
r />L'Oreal said its consumer products division, which includes its L'Oreal Paris range of mascaras and Elseve hair gloss and accounts for more than a third of its revenues, grew 11.1% on a like-for-like ba
r />The company benefited from higher volumes as well as value in the unit, with strong demand in Europe and emerging mark
r />The smaller but fast-growing dermatological beauty unit, which sells La Roche-Posay and CeraVe skincare, grew 21.9%, as it continued to benefit from medical recommendati
r />Sales in the luxury division that markets fragrances such as YSL's Libre and Aesop products acquired last year, grew by 1.8%, beating expectations for a decline, as strong growth in Europe and North America helped offset softness in North A
r />North Asia suffered from an unfavourable comparison base in Travel Retail and sluggish market growth in mainland China, the company s
r />Jefferies analysts said travel retail sales were also dented by a Chinese government crackdown on resellers of foreign consumer products, known as "daig
r />L'Oreal has the biggest share of China's luxury beauty market, or about 34%, Chief Executive Nicolas Hieronimus told analysts on a c
r />"We are unhappy about the fact that this market is not rebounding the way we expected it to rebound," he said, but added that the company is still outperforming the mar
r />The company grew 6.2% in China, compared to less than 1% in the broader market, he said.
r />Shares in L'Oreal, Europe's 6th most valuable listed company, with a market capitalisation of about 220 billion euro ($234.26 billion), have lost 6% so far this year, compared to a 5% fall at U.S. peer Estee Lauder. ($1 = 0.9383 eu
r />(Reporting by Dominique Patton and Mimosa Spencer; Editing by Susan Fenton and Barbara Lewis)